Explore 2 Growth
2 investments found
Lipigon Pharmaceuticals AB
Lipigon utvecklar läkemedel för sjukdomar som beror på störningar i hur fetter hanteras i kroppen.
Funded
SEK 6,800,385
Target
SEK 7,996,815
Capital Target
SEK 9,996,090
Min. Raise
SEK 7,996,815
Percent of Equity Offered
33%
Valuation of equity
SEK 30000000
End Date
19 January 2019
EMPE Diagnostics
EMPE Diagnostics offers rapid and easy to use diagnostic solutions for infectious diseases with an initial focus on tuberculosis.
Funded
SEK 9,722,385
Target
SEK 4,000,000
Capital Target
SEK 9,722,385
Min. Raise
SEK 3,988,710
Percent of Equity Offered
42%
Valuation of equity
SEK 23000000
End Date
10 August 2018